Vascular Biogenics Ltd. (VBL Therapeutics)

www.vblrx.com

High-Tech Company

Acquired by Notable Labs

Graduated from: Eager BioGroup Ltd.

TECH VERTICALS

Biopharmaceuticals Biotechnology, Cancer, MedTech, Oncology, Therapeutics, Treatment

General Data

Sector

Biomed

TECHNOLOGY

VBL Therapeutics’ lead product candidate from our oncology program, VB-111, is a first-in-class gene-therapy based agent for solid tumor indications with current clinical trials in recurrent Glioblastoma multiforme (rGBM), thyroid cancer an...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

Fourth Round

Jan. 01, 2011

R&D

$63m

$80m

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated:	Oct 22, 2023
IVC Number:	A1000000004706